153 related articles for article (PubMed ID: 38110554)
1. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.
Brennan MS; Brinkmann K; Romero Sola G; Healey G; Gibson L; Gangoda L; Potts MA; Lieschke E; Wilcox S; Strasser A; Herold MJ; Janic A
Cell Death Differ; 2024 Feb; 31(2):159-169. PubMed ID: 38110554
[TBL] [Abstract][Full Text] [Related]
2. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
3. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
4. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett KT; Kaiser AM; Morgens DW; Boutelle AM; Seoane JA; Van Nostrand EL; Zhu C; Houlihan SL; Mello SS; Yee BA; McClendon J; Pierce SE; Winters IP; Wang M; Connolly AJ; Lowe SW; Curtis C; Yeo GW; Winslow MM; Bassik MC; Attardi LD
Mol Cell; 2020 Nov; 80(3):452-469.e9. PubMed ID: 33157015
[TBL] [Abstract][Full Text] [Related]
5. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
Best SA; Vandenberg CJ; Abad E; Whitehead L; Guiu L; Ding S; Brennan MS; Strasser A; Herold MJ; Sutherland KD; Janic A
Cell Death Dis; 2020 Oct; 11(10):877. PubMed ID: 33082333
[TBL] [Abstract][Full Text] [Related]
6. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
[TBL] [Abstract][Full Text] [Related]
7. Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction.
Sperka T; Song Z; Morita Y; Nalapareddy K; Guachalla LM; Lechel A; Begus-Nahrmann Y; Burkhalter MD; Mach M; Schlaudraff F; Liss B; Ju Z; Speicher MR; Rudolph KL
Nat Cell Biol; 2011 Dec; 14(1):73-9. PubMed ID: 22138576
[TBL] [Abstract][Full Text] [Related]
8. Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Thomas AF; Kelly GL; Strasser A
Cell Death Differ; 2022 May; 29(5):961-971. PubMed ID: 35396345
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.
Indeglia A; Murphy ME
Crit Rev Biochem Mol Biol; 2024; 59(1-2):128-138. PubMed ID: 38661126
[No Abstract] [Full Text] [Related]
10. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa.
Kerr JB; Hutt KJ; Michalak EM; Cook M; Vandenberg CJ; Liew SH; Bouillet P; Mills A; Scott CL; Findlay JK; Strasser A
Mol Cell; 2012 Nov; 48(3):343-52. PubMed ID: 23000175
[TBL] [Abstract][Full Text] [Related]
12. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
13. p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
Thakur VS; Ruhul Amin AR; Paul RK; Gupta K; Hastak K; Agarwal MK; Jackson MW; Wald DN; Mukhtar H; Agarwal ML
Cancer Lett; 2010 Oct; 296(2):225-32. PubMed ID: 20444544
[TBL] [Abstract][Full Text] [Related]
14. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute.
Michalak EM; Villunger A; Adams JM; Strasser A
Cell Death Differ; 2008 Jun; 15(6):1019-29. PubMed ID: 18259198
[TBL] [Abstract][Full Text] [Related]
15. iNOS/NO is required for IRF1 activation in response to liver ischemia-reperfusion in mice.
Du Q; Luo J; Yang MQ; Liu Q; Heres C; Yan YH; Stolz D; Geller DA
Mol Med; 2020 Jun; 26(1):56. PubMed ID: 32517688
[TBL] [Abstract][Full Text] [Related]
16. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma.
Wu WS; Heinrichs S; Xu D; Garrison SP; Zambetti GP; Adams JM; Look AT
Cell; 2005 Nov; 123(4):641-53. PubMed ID: 16286009
[TBL] [Abstract][Full Text] [Related]
17. Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.
Jabbour AM; Daunt CP; Green BD; Vogel S; Gordon L; Lee RS; Silke N; Pearson RB; Vandenberg CJ; Kelly PN; Nutt SL; Strasser A; Borner C; Ekert PG
Blood; 2010 Jan; 115(2):344-52. PubMed ID: 19965665
[TBL] [Abstract][Full Text] [Related]
18. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
[TBL] [Abstract][Full Text] [Related]
19. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Puma-dependent and Puma-independent neuronal cell death pathways following prolonged proteasomal inhibition.
Tuffy LP; Concannon CG; D'Orsi B; King MA; Woods I; Huber HJ; Ward MW; Prehn JH
Mol Cell Biol; 2010 Dec; 30(23):5484-501. PubMed ID: 20921277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]